Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib

Treating neutropenia and neutrophil dysfunction in glycogen storage disease IB with an SGLT2-inhibitor

(2020) Saskia B Wortmann et al.   BLOOD

Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency

(2019) Maria Veiga-da-Cunha et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length

(2018) Amanda M. Li et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Neutropenia in glycogen storage disease Ib

(2018) David C. Dale et al.   CURRENT OPINION IN HEMATOLOGY

Model analysis of effect of canagliflozin (Invokana), a sodium–glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol

(2016) Danielle Fortuna et al.   CLINICA CHIMICA ACTA

Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib

(2014) H. S. Jun et al.   BLOOD

Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

(2014) Priya S. Kishnani et al.   GENETICS IN MEDICINE

Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes

(2013) R. A. DeFronzo et al.   DIABETES CARE

Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy

(2010) Janice Y. Chou et al.   Nature Reviews Endocrinology

Neutropenia in type Ib glycogen storage disease

(2009) Janice Y Chou et al.   CURRENT OPINION IN HEMATOLOGY

Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib

(2008) S. Y. Kim et al.   BLOOD